Humira (adalimumab) is a prescription drug that is used to treat a number of conditions, including rheumatoid arthritis, Crohn’s disease, and psoriatic arthritis. Like all medications, Humira can cause side effects.
Most Common Side Effects
The most common side effects of Humira include:
- Upper respiratory tract infection
- Sinus infection
- Stomach pain
Less Common Side Effects
Less common side effects of Humira include:
- Allergic reactions, including hives and difficulty breathing
- Chest pain or tightness
- Rapid heartbeat
- Swelling of the face, lips, tongue, or throat
- Depression or suicidal thoughts
- Severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis
It is important to report any side effects to a healthcare provider.
Humira is also available in a pen form called Humira Pen. The Humira Pen is a prefilled, disposable injector that is used to administer the medication. It is designed to be easy to use and can be self-administered by the patient.
To use the Humira Pen, follow these steps:
- Remove the pen from the refrigerator and allow it to come to room temperature for at least 30 minutes.
- Wash your hands with soap and water.
- Remove the pen cap.
- Dial the pen to the prescribed dose.
- Pinch an area of skin on your stomach, thigh, or upper arm.
- Insert the needle into the pinched skin at a 90-degree angle.
- Push down on the plunger to inject the medication.
- After the injection, remove the needle and dispose of it safely.
It is important to follow the instructions provided by a healthcare provider when using the Humira Pen.
Humira is also available as a solution for injection. The injection is administered using a needle and syringe. It is typically given by a healthcare provider, but it can also be self-administered by the patient.
The cost of a Humira injection can vary depending on a number of factors, including the dosage and the number of injections required.
According to GoodRx, the average cash price for a single Humira injection is around $1,500. It is important to check with a healthcare provider or pharmacist for the most up-to-date pricing information.
Humira is used to treat a number of conditions that are characterized by inflammation, including rheumatoid arthritis, Crohn’s disease, and psoriatic arthritis.
It works by blocking the action of tumor necrosis factor (TNF), a protein that plays a key role in the inflammation process. By blocking TNF, Humira can reduce inflammation and improve symptoms of these conditions.
The dose of Humira will depend on the condition being treated and the patient’s response to the medication. It is important to follow the dosing instructions provided by a healthcare provider.
Humira is typically given as an injection or injection pen, and it is usually administered every other week.
AbbVie is a pharmaceutical company that manufactures Humira (adalimumab), a prescription drug used to treat a number of conditions, including rheumatoid arthritis, Crohn’s disease, and psoriatic arthritis.
One key aspect of the pharmaceutical industry is the control of patents, which give the patent holder exclusive rights to produce and sell a particular product.
In the case of Humira, AbbVie holds the patent and has exclusive rights to produce and sell the drug.
The patent for Humira was originally set to expire in 2016, but AbbVie was able to extend its exclusivity through a number of patent settlement agreements with other pharmaceutical companies.
As a result, generic versions of Humira are not expected to be available in the United States until 2023.
The control of patents and exclusivity periods is a controversial issue in the pharmaceutical industry.
On one hand, patents provide an incentive for companies to invest in the research and development of new medications.
On the other hand, the high cost of patented medications can be a barrier for some patients who may not be able to afford them.
In the case of Humira, the high cost of the drug has been a source of controversy, with some arguing that the high price is due in part to AbbVie’s control over the patent.
The high cost of Humira in the United States has also been attributed to a variety of other factors, including the high cost of research and development, marketing and advertising, and the lack of a system in place for negotiating drug prices with pharmaceutical companies.